PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1681483
PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1681483
Global Syndromic Multiplex Diagnostics Market Size Study, by Type (Respiratory, Gastrointestinal, Central Nervous System), by End Use (Hospitals, Diagnostic Laboratories, Others), and Regional Forecasts 2022-2032
The Global Syndromic Multiplex Diagnostics Market was valued at approximately USD 2.81 billion in 2023 and is anticipated to grow at a CAGR of 3.91% over the forecast period 2024-2032. The increasing demand for rapid and accurate diagnostics, advancements in molecular diagnostic technologies, and the rising prevalence of infectious diseases are among the key factors driving market growth. The widespread occurrence of diseases such as respiratory infections, gastrointestinal diseases, and sexually transmitted infections (STIs) has fueled the demand for syndromic testing. According to the World Health Organization (WHO), in 2023, tuberculosis (TB) caused 1.25 million deaths, with an estimated 10.8 million people developing TB, affecting men, women, and children worldwide. This increasing burden of infectious diseases is significantly boosting the demand for effective diagnostic solutions, driving the growth of the syndromic multiplex diagnostics market.
Advancements in molecular diagnostics have played a crucial role in market expansion. Technologies such as next-generation sequencing (NGS) and advanced polymerase chain reaction (PCR) assays have significantly improved the sensitivity and specificity of syndromic multiplex diagnostics. For example, in September 2024, Roche launched the Cobas Respiratory Flex test, a novel syndromic multiplex PCR assay that can identify up to 15 respiratory pathogens from a single patient sample. This test enhances diagnostic efficiency, provides rapid results, and eliminates the need for multiple tests, ultimately streamlining laboratory workflows and improving patient care.
Moreover, increased investments in research and development (R&D) by market players are further fueling innovation. In September 2024, Seegene partnered with Springer Nature to offer research grants aimed at advancing syndromic PCR diagnostic assays. This initiative focuses on enhancing innovation in molecular diagnostics, encouraging new methodologies and the development of assays for emerging pathogens and mutations. The growing emphasis on diagnostic capabilities for infectious diseases highlights the importance of syndromic multiplex diagnostics in public health advancements.
From a geographical perspective, North America holds the largest market share due to the high prevalence of infectious diseases, strong presence of key market players, and stringent regulatory standards ensuring the adoption of effective diagnostic solutions. Europe is also a significant market, driven by technological advancements and an aging population that is highly susceptible to infections. Meanwhile, Asia-Pacific is expected to witness the fastest growth, particularly in China, India, and Japan, due to developing healthcare infrastructure and growing investments in diagnostic technologies.
Major Market Players Included in This Report Are:
- Abbott Laboratories
- Thermo Fisher Scientific, Inc.
- F. Hoffmann-La Roche Ltd
- Qiagen
- bioMerieux
- DiaSorin S.p.A (Luminex Corporation)
- Hologic, Inc.
- Becton, Dickinson and Company (BD)
- Applied BioCode
- QIAGEN
The Detailed Segments and Sub-Segments of the Market Are Explained Below:
By Type
By End Use
By Region:
Years Considered for the Study Are As Follows:
Key Takeaways:
Table of Contents
Chapter 1. Global Syndromic Multiplex Diagnostics Market Executive Summary
- 1.1. Global Syndromic Multiplex Diagnostics Market Size & Forecast (2022-2032)
- 1.2. Regional Summary
- 1.3. Segmental Summary
- 1.3.1. By Type
- 1.3.2. By End-Use
- 1.4. Key Trends
- 1.5. Recession Impact
- 1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Syndromic Multiplex Diagnostics Market Definition and Research Assumptions
- 2.1. Research Objective
Chapter 3. Global Syndromic Multiplex Diagnostics Market Dynamics
Chapter 4. Global Syndromic Multiplex Diagnostics Market Industry Analysis
Chapter 5. Global Syndromic Multiplex Diagnostics Market Size & Forecasts by Type 2022-2032
Chapter 6. Global Syndromic Multiplex Diagnostics Market Size & Forecasts by End-Use 2022-2032
Chapter 7. Global Syndromic Multiplex Diagnostics Market Size & Forecasts by Region 2022-2032
Chapter 8. Competitive Intelligence
Chapter 9. Research Process
